XIAP, or X-linked inhibitor of apoptosis protein, is a critical regulator of cell death, playing a pivotal role in inhibiting apoptosis by binding and inhibiting caspases, particularly caspase-3, -7, and -9. Mutations or dysregulation of XIAP are linked to various diseases, including immune deficiencies and cancers, making it a significant target for therapeutic intervention.